FDA's Forecast for Globalization
This article was originally published in RPM Report
Executive Summary
On June 20th, FDA released its plan to enhance oversight of the global supply chain for regulated industry's. In the first chapter of the report--Pathway to Global Product Safety and Quality--the agency outlines its view of globalization, and the forces that will reshape the global pharma industry over the next decade.